Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 56104.8 | nM | 19743809 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 84918.05 | nM | 19113967 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 37411.06 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 39536.66 | nM | 26636180 | |
NPT366 | Individual Protein | Quinone reductase 2 | Homo sapiens | IC50 | = | 37100 | nM | 11754615 |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 62661.39 | nM | 19105653 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 22855.99 | nM | 16872149 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 7079.46 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 20749.14 | nM | 23411074 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 33300 | nM | 26083682 |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 37757.22 | nM | 22276775 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 53210.83 | nM | 8133298 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 19230.92 | nM | 23282083 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | ED50 | > | 25 | nM | 16413186 |
NPT83 | Cell Line | MCF7 | Homo sapiens | ED50 | > | 25 | nM | 16413186 |
NPT3958 | Cell Line | MLM | ED50 | > | 25 | nM | 16413186 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | ED50 | > | 25 | nM | 16413186 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 46558.61 | nM | 22443262 | |
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 28000 | nM | 20970331 |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 30478.95 | nM | 22365879 | |
NPT2 | Others | Unspecified | IC50 | = | 2810 | nM | 20403695 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 22855.99 | nM | 23252603 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 19815.27 | nM | 10.6019/CHEMBL1201861 | |
NPT916 | Cell Line | SK-MEL | Homo sapiens | IC50 | = | 60000 | nM | 24588105 |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 8000 | nM | 24613456 |
NPT660 | Cell Line | SW480 | Homo sapiens | Activity | = | 15 | % | 25993269 |
NPT2 | Others | Unspecified | Ratio | = | 190 | 16038541 | ||
NPT2 | Others | Unspecified | Ratio | = | 0.25 | 16038541 | ||
NPT1603 | Individual Protein | Cytochrome P450 1A1 | Homo sapiens | IC50 | = | 750 | nM | 15217276 |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 46881.34 | nM | 17125218 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 36224.3 | nM | 8496706 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 83368.12 | nM | 17067176 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 23713.74 | nM | DrugMatrix in vitro pharmacology data | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 30199.52 | nM | 23445496 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 31988.95 | nM | 10.6019/CHEMBL1201861 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 19633.6 | nM | 25768706 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 15452.54 | nM | 2691635 | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 25822.6 | nM | 25136754 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 31332.86 | nM | 21459003 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 39627.8 | nM | 10395505 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 39810.72 | nM | 18824363 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 25703.96 | nM | 23543830 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 41114.97 | nM | 23398362 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 100000 | nM | 12193011 | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 20892.96 | nM | 17402783 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 49203.95 | nM | 21035339 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 23067.47 | nM | 25237727 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 22181.96 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 19275.25 | nM | 1402961 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 46344.69 | nM | 25918997 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 19010.78 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 2350 | nM | 8158165 | |
NPT81 | Cell Line | A549 | Homo sapiens | Activity | = | 77.1 | % | 12193039 |
NPT660 | Cell Line | SW480 | Homo sapiens | Activity | = | 10 | % | 20439614 |
NPT660 | Cell Line | SW480 | Homo sapiens | Activity | = | 25 | % | 20439614 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 57016.43 | nM | 15920768 | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 23604.78 | nM | DrugMatrix in vitro pharmacology data | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 30902.95 | nM | 18183025 | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 73620.71 | nM | 18183025 | |
NPT81 | Cell Line | A549 | Homo sapiens | ED50 | > | 25 | nM | 18077363 |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | IC50 | = | 570000 | nM | 20031422 |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 19860.95 | nM | 19105653 | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 23713.74 | nM | 15165148 | |
NPT1604 | Individual Protein | Cytochrome P450 1B1 | Homo sapiens | IC50 | = | 3000 | nM | 20050684 |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 34040.82 | nM | 18278870 | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | IC50 | = | 2860 | nM | 19223615 |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 18836.49 | nM | 11087586 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 41304.75 | nM | 24673739 | |
NPT179 | Cell Line | A2780 | Homo sapiens | IC50 | = | 2060 | nM | 17850214 |
NPT2 | Others | Unspecified | IC50 | = | 2860 | nM | 23398362 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 33300 | nM | 19691309 |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 39902.49 | nM | 10096862 | |
NPT2 | Others | Unspecified | IC50 | = | 2460 | nM | 12444692 | |
NPT886 | Cell Line | NIH3T3 | Mus musculus | IC50 | = | 3680 | nM | 12762798 |
NPT3962 | Individual Protein | Myc proto-oncogene protein | Homo sapiens | Inhibition | < | 40 | % | 22694318 |
NPT2 | Others | Unspecified | Inhibition | < | 40 | % | 22694318 | |
NPT2 | Others | Unspecified | IC50 | = | 80000 | nM | 22694318 | |
NPT3961 | Individual Protein | Forkhead box protein O1 | Homo sapiens | Inhibition | < | 40 | % | 22694318 |
NPT2 | Others | Unspecified | Inhibition | < | 40 | % | 22703109 | |
NPT2 | Others | Unspecified | IC50 | = | 90000 | nM | 22703109 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 22181.96 | nM | 20430633 | |
NPT660 | Cell Line | SW480 | Homo sapiens | IC50 | = | 100000 | nM | 8759172 |
NPT660 | Cell Line | SW480 | Homo sapiens | Activity | = | 50 | % | 25856683 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 45185.59 | nM | 24131240 | |
NPT2 | Others | Unspecified | Inhibition | < | 40 | % | 8229009 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 63679.55 | nM | 17638695 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 28054.34 | nM | 20591538 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 76913.04 | nM | 18332172 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 32885.16 | nM | Open TG-GATES in vivo data: Hematology | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 28707.81 | nM | DrugMatrix in vivo data: Hematology | |
NPT2 | Others | Unspecified | Activity | = | 101.3 | % | 25871540 | |
NPT2 | Others | Unspecified | Inhibition | < | 40 | % | 16792422 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 19098.53 | nM | 8229009 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 1890 | nM | 10.1016/j.cropro.2005.01.009 |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 24660.39 | nM | 10.1039/C0MD00241K | |
NPT165 | Cell Line | HeLa | Homo sapiens | Inhibition | < | 40 | % | 12828469 |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 100000 | nM | 12828469 |
NPT2 | Others | Unspecified | IC50 | = | 80000 | nM | 12828469 | |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 3040 | nM | 16872140 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC123948 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.973 | High Similarity | NPC475961 |
0.973 | High Similarity | NPC254625 |
0.9558 | High Similarity | NPC472596 |
0.9558 | High Similarity | NPC166759 |
0.9537 | High Similarity | NPC203924 |
0.9474 | High Similarity | NPC477886 |
0.9469 | High Similarity | NPC474565 |
0.9391 | High Similarity | NPC262253 |
0.9391 | High Similarity | NPC71579 |
0.9391 | High Similarity | NPC473411 |
0.9391 | High Similarity | NPC261661 |
0.9381 | High Similarity | NPC15805 |
0.9364 | High Similarity | NPC204120 |
0.9352 | High Similarity | NPC82016 |
0.9352 | High Similarity | NPC165386 |
0.931 | High Similarity | NPC282496 |
0.931 | High Similarity | NPC233526 |
0.9259 | High Similarity | NPC245115 |
0.9167 | High Similarity | NPC35543 |
0.9153 | High Similarity | NPC203133 |
0.9153 | High Similarity | NPC105925 |
0.9153 | High Similarity | NPC251855 |
0.9153 | High Similarity | NPC117214 |
0.9153 | High Similarity | NPC472093 |
0.9153 | High Similarity | NPC299584 |
0.9153 | High Similarity | NPC57490 |
0.9153 | High Similarity | NPC116907 |
0.9153 | High Similarity | NPC193544 |
0.9153 | High Similarity | NPC221077 |
0.9153 | High Similarity | NPC475169 |
0.9153 | High Similarity | NPC17943 |
0.9153 | High Similarity | NPC298757 |
0.9153 | High Similarity | NPC208950 |
0.9153 | High Similarity | NPC82483 |
0.9153 | High Similarity | NPC265483 |
0.9153 | High Similarity | NPC233410 |
0.9138 | High Similarity | NPC75713 |
0.913 | High Similarity | NPC61516 |
0.913 | High Similarity | NPC10932 |
0.913 | High Similarity | NPC232084 |
0.913 | High Similarity | NPC247364 |
0.9076 | High Similarity | NPC244364 |
0.9076 | High Similarity | NPC285725 |
0.9076 | High Similarity | NPC112571 |
0.9076 | High Similarity | NPC78974 |
0.9076 | High Similarity | NPC50683 |
0.9076 | High Similarity | NPC223136 |
0.9076 | High Similarity | NPC18924 |
0.9076 | High Similarity | NPC214406 |
0.9076 | High Similarity | NPC28730 |
0.9076 | High Similarity | NPC103823 |
0.9076 | High Similarity | NPC44748 |
0.9052 | High Similarity | NPC199023 |
0.9043 | High Similarity | NPC308217 |
0.9043 | High Similarity | NPC226629 |
0.9035 | High Similarity | NPC304208 |
0.9035 | High Similarity | NPC52464 |
0.9 | High Similarity | NPC246620 |
0.9 | High Similarity | NPC324112 |
0.9 | High Similarity | NPC159968 |
0.9 | High Similarity | NPC210355 |
0.9 | High Similarity | NPC124452 |
0.9 | High Similarity | NPC194841 |
0.9 | High Similarity | NPC236791 |
0.9 | High Similarity | NPC74817 |
0.9 | High Similarity | NPC474119 |
0.9 | High Similarity | NPC293054 |
0.9 | High Similarity | NPC282000 |
0.9 | High Similarity | NPC242032 |
0.9 | High Similarity | NPC127587 |
0.9 | High Similarity | NPC82679 |
0.9 | High Similarity | NPC169474 |
0.8992 | High Similarity | NPC234400 |
0.8992 | High Similarity | NPC60885 |
0.8983 | High Similarity | NPC136319 |
0.8983 | High Similarity | NPC95168 |
0.8983 | High Similarity | NPC197757 |
0.8983 | High Similarity | NPC228922 |
0.8966 | High Similarity | NPC222175 |
0.8957 | High Similarity | NPC63083 |
0.8938 | High Similarity | NPC228287 |
0.8938 | High Similarity | NPC180508 |
0.8926 | High Similarity | NPC186843 |
0.8926 | High Similarity | NPC31707 |
0.8926 | High Similarity | NPC222127 |
0.8926 | High Similarity | NPC474623 |
0.8926 | High Similarity | NPC82862 |
0.8926 | High Similarity | NPC210674 |
0.8926 | High Similarity | NPC206615 |
0.8926 | High Similarity | NPC474651 |
0.8926 | High Similarity | NPC98631 |
0.8926 | High Similarity | NPC470213 |
0.8919 | High Similarity | NPC2682 |
0.8917 | High Similarity | NPC9891 |
0.8917 | High Similarity | NPC186845 |
0.8917 | High Similarity | NPC76451 |
0.8917 | High Similarity | NPC88297 |
0.8917 | High Similarity | NPC223953 |
0.8898 | High Similarity | NPC41562 |
0.8898 | High Similarity | NPC288238 |
0.887 | High Similarity | NPC259638 |
0.887 | High Similarity | NPC33271 |
0.8852 | High Similarity | NPC469963 |
0.8852 | High Similarity | NPC3439 |
0.8852 | High Similarity | NPC10225 |
0.8852 | High Similarity | NPC228769 |
0.8852 | High Similarity | NPC226788 |
0.8852 | High Similarity | NPC210623 |
0.8852 | High Similarity | NPC285339 |
0.8852 | High Similarity | NPC218856 |
0.8852 | High Similarity | NPC273295 |
0.8852 | High Similarity | NPC470633 |
0.8852 | High Similarity | NPC202582 |
0.8852 | High Similarity | NPC170844 |
0.8852 | High Similarity | NPC222004 |
0.8852 | High Similarity | NPC58164 |
0.8852 | High Similarity | NPC474227 |
0.8852 | High Similarity | NPC470258 |
0.8852 | High Similarity | NPC476968 |
0.8852 | High Similarity | NPC469951 |
0.8852 | High Similarity | NPC190629 |
0.885 | High Similarity | NPC165106 |
0.8843 | High Similarity | NPC8050 |
0.8843 | High Similarity | NPC202904 |
0.8843 | High Similarity | NPC471986 |
0.8843 | High Similarity | NPC473093 |
0.8843 | High Similarity | NPC189248 |
0.8843 | High Similarity | NPC473092 |
0.8824 | High Similarity | NPC108545 |
0.8814 | High Similarity | NPC145780 |
0.8803 | High Similarity | NPC229401 |
0.8793 | High Similarity | NPC474612 |
0.8783 | High Similarity | NPC193067 |
0.878 | High Similarity | NPC51840 |
0.878 | High Similarity | NPC299221 |
0.878 | High Similarity | NPC224157 |
0.878 | High Similarity | NPC472338 |
0.878 | High Similarity | NPC63574 |
0.878 | High Similarity | NPC234488 |
0.878 | High Similarity | NPC79184 |
0.878 | High Similarity | NPC311680 |
0.878 | High Similarity | NPC476399 |
0.878 | High Similarity | NPC192687 |
0.878 | High Similarity | NPC126836 |
0.878 | High Similarity | NPC307042 |
0.877 | High Similarity | NPC207702 |
0.877 | High Similarity | NPC154866 |
0.877 | High Similarity | NPC149008 |
0.877 | High Similarity | NPC54321 |
0.877 | High Similarity | NPC283114 |
0.877 | High Similarity | NPC281864 |
0.877 | High Similarity | NPC28765 |
0.877 | High Similarity | NPC328682 |
0.8761 | High Similarity | NPC280606 |
0.875 | High Similarity | NPC5796 |
0.875 | High Similarity | NPC206487 |
0.875 | High Similarity | NPC122792 |
0.875 | High Similarity | NPC228972 |
0.8739 | High Similarity | NPC194626 |
0.8739 | High Similarity | NPC270326 |
0.8718 | High Similarity | NPC20674 |
0.8718 | High Similarity | NPC119949 |
0.871 | High Similarity | NPC472597 |
0.871 | High Similarity | NPC470096 |
0.871 | High Similarity | NPC474017 |
0.871 | High Similarity | NPC469625 |
0.871 | High Similarity | NPC192255 |
0.871 | High Similarity | NPC470095 |
0.871 | High Similarity | NPC471983 |
0.871 | High Similarity | NPC149337 |
0.871 | High Similarity | NPC474238 |
0.871 | High Similarity | NPC469613 |
0.871 | High Similarity | NPC30043 |
0.871 | High Similarity | NPC473412 |
0.871 | High Similarity | NPC469698 |
0.8707 | High Similarity | NPC474933 |
0.8704 | High Similarity | NPC12714 |
0.8704 | High Similarity | NPC310905 |
0.8699 | High Similarity | NPC190144 |
0.8699 | High Similarity | NPC212015 |
0.8696 | High Similarity | NPC475815 |
0.8696 | High Similarity | NPC473264 |
0.8696 | High Similarity | NPC47194 |
0.8689 | High Similarity | NPC252131 |
0.8689 | High Similarity | NPC470699 |
0.8689 | High Similarity | NPC266555 |
0.8689 | High Similarity | NPC236760 |
0.8673 | High Similarity | NPC296920 |
0.8673 | High Similarity | NPC90520 |
0.8667 | High Similarity | NPC121115 |
0.8667 | High Similarity | NPC84086 |
0.8655 | High Similarity | NPC216929 |
0.8655 | High Similarity | NPC126935 |
0.8655 | High Similarity | NPC312713 |
0.8655 | High Similarity | NPC57268 |
0.8655 | High Similarity | NPC49341 |
0.8655 | High Similarity | NPC172676 |
0.8655 | High Similarity | NPC65933 |
0.8655 | High Similarity | NPC310373 |
0.864 | High Similarity | NPC160991 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC123948 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9391 | High Similarity | NPD2981 | Phase 2 |
0.931 | High Similarity | NPD2983 | Phase 2 |
0.931 | High Similarity | NPD2982 | Phase 2 |
0.9 | High Similarity | NPD3018 | Phase 2 |
0.8852 | High Similarity | NPD3027 | Phase 3 |
0.885 | High Similarity | NPD5283 | Phase 1 |
0.8547 | High Similarity | NPD5536 | Phase 2 |
0.8308 | Intermediate Similarity | NPD3539 | Phase 1 |
0.8244 | Intermediate Similarity | NPD3540 | Phase 1 |
0.8175 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8095 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8065 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.8062 | Intermediate Similarity | NPD1613 | Approved |
0.8062 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8049 | Intermediate Similarity | NPD3705 | Approved |
0.8034 | Intermediate Similarity | NPD228 | Approved |
0.8 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7941 | Intermediate Similarity | NPD7124 | Phase 2 |
0.7883 | Intermediate Similarity | NPD4357 | Discontinued |
0.7788 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7752 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7744 | Intermediate Similarity | NPD6111 | Discontinued |
0.7724 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7717 | Intermediate Similarity | NPD2922 | Phase 1 |
0.7714 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7661 | Intermediate Similarity | NPD1357 | Approved |
0.7634 | Intermediate Similarity | NPD5109 | Approved |
0.7634 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7634 | Intermediate Similarity | NPD5110 | Phase 2 |
0.7634 | Intermediate Similarity | NPD5111 | Phase 2 |
0.7626 | Intermediate Similarity | NPD5297 | Approved |
0.7619 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7615 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7563 | Intermediate Similarity | NPD5451 | Approved |
0.7552 | Intermediate Similarity | NPD4678 | Approved |
0.7552 | Intermediate Similarity | NPD4675 | Approved |
0.7542 | Intermediate Similarity | NPD1358 | Approved |
0.7518 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7483 | Intermediate Similarity | NPD6055 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD7261 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD4005 | Discontinued |
0.7482 | Intermediate Similarity | NPD2219 | Phase 1 |
0.7479 | Intermediate Similarity | NPD2684 | Approved |
0.7424 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7417 | Intermediate Similarity | NPD3022 | Approved |
0.7417 | Intermediate Similarity | NPD3021 | Approved |
0.7397 | Intermediate Similarity | NPD2801 | Approved |
0.7388 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7377 | Intermediate Similarity | NPD7843 | Approved |
0.7377 | Intermediate Similarity | NPD5535 | Approved |
0.7364 | Intermediate Similarity | NPD4749 | Approved |
0.736 | Intermediate Similarity | NPD1408 | Clinical (unspecified phase) |
0.7353 | Intermediate Similarity | NPD6896 | Approved |
0.7353 | Intermediate Similarity | NPD6895 | Approved |
0.7347 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7339 | Intermediate Similarity | NPD7157 | Approved |
0.7338 | Intermediate Similarity | NPD4237 | Approved |
0.7338 | Intermediate Similarity | NPD3060 | Approved |
0.7338 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7329 | Intermediate Similarity | NPD1934 | Approved |
0.7329 | Intermediate Similarity | NPD37 | Approved |
0.7328 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.7324 | Intermediate Similarity | NPD1424 | Approved |
0.7311 | Intermediate Similarity | NPD3134 | Approved |
0.7302 | Intermediate Similarity | NPD7534 | Approved |
0.7302 | Intermediate Similarity | NPD7533 | Approved |
0.7297 | Intermediate Similarity | NPD3882 | Suspended |
0.7254 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD4055 | Discovery |
0.7248 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD1651 | Approved |
0.7231 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.723 | Intermediate Similarity | NPD6374 | Clinical (unspecified phase) |
0.7218 | Intermediate Similarity | NPD3537 | Clinical (unspecified phase) |
0.7209 | Intermediate Similarity | NPD422 | Phase 1 |
0.7206 | Intermediate Similarity | NPD3657 | Discovery |
0.7203 | Intermediate Similarity | NPD4123 | Phase 3 |
0.7181 | Intermediate Similarity | NPD4966 | Approved |
0.7181 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7181 | Intermediate Similarity | NPD4965 | Approved |
0.7181 | Intermediate Similarity | NPD6788 | Approved |
0.7174 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.7174 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.7172 | Intermediate Similarity | NPD1653 | Approved |
0.7162 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7153 | Intermediate Similarity | NPD1351 | Approved |
0.7153 | Intermediate Similarity | NPD1349 | Approved |
0.7153 | Intermediate Similarity | NPD1350 | Approved |
0.7152 | Intermediate Similarity | NPD5677 | Discontinued |
0.7152 | Intermediate Similarity | NPD5494 | Approved |
0.7143 | Intermediate Similarity | NPD4664 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7133 | Intermediate Similarity | NPD1511 | Approved |
0.7132 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7132 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7122 | Intermediate Similarity | NPD2796 | Approved |
0.7119 | Intermediate Similarity | NPD291 | Approved |
0.7119 | Intermediate Similarity | NPD846 | Approved |
0.7119 | Intermediate Similarity | NPD940 | Approved |
0.7111 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7111 | Intermediate Similarity | NPD3145 | Approved |
0.7111 | Intermediate Similarity | NPD3144 | Approved |
0.7109 | Intermediate Similarity | NPD5585 | Approved |
0.7107 | Intermediate Similarity | NPD290 | Approved |
0.7105 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7092 | Intermediate Similarity | NPD4162 | Approved |
0.7086 | Intermediate Similarity | NPD6234 | Discontinued |
0.7077 | Intermediate Similarity | NPD1091 | Approved |
0.7071 | Intermediate Similarity | NPD1375 | Discontinued |
0.7059 | Intermediate Similarity | NPD1726 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD6232 | Discontinued |
0.7059 | Intermediate Similarity | NPD4606 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7054 | Intermediate Similarity | NPD17 | Approved |
0.7054 | Intermediate Similarity | NPD6516 | Phase 2 |
0.7054 | Intermediate Similarity | NPD5846 | Approved |
0.7045 | Intermediate Similarity | NPD8651 | Approved |
0.7043 | Intermediate Similarity | NPD9296 | Approved |
0.7043 | Intermediate Similarity | NPD2933 | Approved |
0.7043 | Intermediate Similarity | NPD2934 | Approved |
0.7042 | Intermediate Similarity | NPD6658 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD2669 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD7095 | Approved |
0.7034 | Intermediate Similarity | NPD1512 | Approved |
0.7034 | Intermediate Similarity | NPD5261 | Clinical (unspecified phase) |
0.7031 | Intermediate Similarity | NPD1182 | Approved |
0.7027 | Intermediate Similarity | NPD5090 | Approved |
0.7027 | Intermediate Similarity | NPD5089 | Approved |
0.7025 | Intermediate Similarity | NPD968 | Approved |
0.7021 | Intermediate Similarity | NPD2808 | Discontinued |
0.7015 | Intermediate Similarity | NPD9494 | Approved |
0.7014 | Intermediate Similarity | NPD6799 | Approved |
0.7013 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7013 | Intermediate Similarity | NPD5242 | Approved |
0.7013 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7008 | Intermediate Similarity | NPD3596 | Phase 2 |
0.7007 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7007 | Intermediate Similarity | NPD1240 | Approved |
0.7 | Intermediate Similarity | NPD5353 | Approved |
0.7 | Intermediate Similarity | NPD3847 | Discontinued |
0.6992 | Remote Similarity | NPD4750 | Phase 3 |
0.6983 | Remote Similarity | NPD2860 | Approved |
0.6983 | Remote Similarity | NPD2859 | Approved |
0.6978 | Remote Similarity | NPD4538 | Approved |
0.6978 | Remote Similarity | NPD4536 | Approved |
0.6978 | Remote Similarity | NPD4537 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD5691 | Approved |
0.6972 | Remote Similarity | NPD5177 | Phase 3 |
0.6972 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.697 | Remote Similarity | NPD5327 | Phase 3 |
0.697 | Remote Similarity | NPD1669 | Approved |
0.6968 | Remote Similarity | NPD6168 | Clinical (unspecified phase) |
0.6968 | Remote Similarity | NPD6166 | Phase 2 |
0.6968 | Remote Similarity | NPD6167 | Clinical (unspecified phase) |
0.6963 | Remote Similarity | NPD1008 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD230 | Phase 1 |
0.6957 | Remote Similarity | NPD1933 | Approved |
0.6954 | Remote Similarity | NPD4868 | Clinical (unspecified phase) |
0.695 | Remote Similarity | NPD7266 | Discontinued |
0.6949 | Remote Similarity | NPD3020 | Approved |
0.6947 | Remote Similarity | NPD1281 | Approved |
0.694 | Remote Similarity | NPD6584 | Phase 3 |
0.6933 | Remote Similarity | NPD4585 | Approved |
0.6929 | Remote Similarity | NPD6671 | Approved |
0.6929 | Remote Similarity | NPD1510 | Phase 2 |
0.6929 | Remote Similarity | NPD709 | Approved |
0.6929 | Remote Similarity | NPD3748 | Approved |
0.6923 | Remote Similarity | NPD4626 | Approved |
0.6923 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6331 | Phase 2 |
0.6923 | Remote Similarity | NPD2668 | Approved |
0.6923 | Remote Similarity | NPD3892 | Phase 2 |
0.6923 | Remote Similarity | NPD2423 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD2667 | Approved |
0.6923 | Remote Similarity | NPD4110 | Phase 3 |
0.6923 | Remote Similarity | NPD7466 | Approved |
0.6923 | Remote Similarity | NPD2107 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD7473 | Discontinued |
0.6913 | Remote Similarity | NPD6386 | Approved |
0.6913 | Remote Similarity | NPD6385 | Approved |
0.6906 | Remote Similarity | NPD2492 | Phase 1 |
0.6906 | Remote Similarity | NPD2653 | Approved |
0.6906 | Remote Similarity | NPD1607 | Approved |
0.6899 | Remote Similarity | NPD6581 | Approved |
0.6899 | Remote Similarity | NPD6580 | Approved |
0.6894 | Remote Similarity | NPD1608 | Approved |
0.6891 | Remote Similarity | NPD3028 | Approved |
0.6884 | Remote Similarity | NPD2238 | Phase 2 |
0.6879 | Remote Similarity | NPD2438 | Suspended |
0.6879 | Remote Similarity | NPD8252 | Approved |
0.6879 | Remote Similarity | NPD8251 | Approved |
0.6879 | Remote Similarity | NPD8099 | Discontinued |
0.6875 | Remote Similarity | NPD5241 | Discontinued |
0.6863 | Remote Similarity | NPD919 | Approved |
0.6853 | Remote Similarity | NPD1652 | Phase 2 |
0.6853 | Remote Similarity | NPD6674 | Discontinued |
0.6849 | Remote Similarity | NPD4584 | Approved |
0.6849 | Remote Similarity | NPD3688 | Clinical (unspecified phase) |
PubChem CID   | 5387294 |
ChEMBL   | CHEMBL44509 |
ZINC   |
Molecular Weight:   | 300.14 |
ALogP:   | 0.2606 |
MLogP:   | 3 |
XLogP:   | 4.338 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 36.92 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 0 |
# Rings:   | 2 |
# Heavy Atoms:   | 22 |